Cargando…
Clinical feature difference between juvenile amyotrophic lateral sclerosis with SPTLC1 and FUS mutations
BACKGROUND: Juvenile amyotrophic lateral sclerosis (JALS) is an uncommon form of amyotrophic lateral sclerosis whose age at onset (AAO) is defined as prior to 25 years. FUS mutations are the most common cause of JALS. SPTLC1 was recently identified as a disease-causative gene for JALS, which has rar...
Autores principales: | Wang, Peishan, Wei, Qiao, Li, Hongfu, Wu, Zhi-Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106144/ https://www.ncbi.nlm.nih.gov/pubmed/36801857 http://dx.doi.org/10.1097/CM9.0000000000002495 |
Ejemplares similares
-
Mutation screening of SPTLC1 and SPTLC2 in amyotrophic lateral sclerosis
por: Li, Chunyu, et al.
Publicado: (2023) -
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis
por: Johnson, Janel O., et al.
Publicado: (2021) -
Clinical and Genetic Features of Patients with Juvenile Amyotrophic Lateral Sclerosis with Fused in Sarcoma (FUS) Mutation
por: Yu, Xiaolong, et al.
Publicado: (2018) -
Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis
por: Naumann, Marcel, et al.
Publicado: (2019) -
De novo FUS P525L mutation in Juvenile amyotrophic lateral sclerosis with dysphonia and diplopia
por: Leblond, Claire S., et al.
Publicado: (2016)